Human SLC25A13 (Citrin) knockout HeLa cell lysate (ab258192)
Properties
-
Storage instructions
Store at -80°C. Please refer to protocols. -
Components 1 kit ab260495 - Human SLC25A13 knockout HeLa cell lysate 1 x 100µg ab255929 - Human wild-type HeLa cell lysate 1 x 100µg -
Research areas
-
Cell type
epithelial -
Disease
Adenocarcinoma -
Gender
Female -
STR Analysis
Amelogenin X D5S818: 11, 12 D13S317: 12, 13.3 D7S820: 8, 12 D16S539: 9, 10 vWA: 16, 18 TH01: 7 TPOX: 8,12 CSF1PO: 9, 10
Images
-
Western blot - Human SLC25A13 (Citrin) knockout HeLa cell lysate (ab258192)Lane 1: Wild-type HeLa cell lysate (20µg)
Lane 2: SLC25A13 knockout HeLa cell lysate (20µg)
Lanes 1- 2: Merged signal (red and green). Green - ab167166 observed at 70 kDa. Red - loading control ab8245 observed at 37 kDa.
ab167166 Recombinant Anti-SLC25A13/Citrin antibody [EPR9969(B)] was shown to specifically react with SLC25A13 in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab265668 (knockout cell lysate ab258192) was used. Wild-type and SLC25A13 knockout samples were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab167166 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging. -
Sanger Sequencing - Human SLC25A13 knockout HeLa cell lysate (ab258192)Allele-1: 1 bp deletion in exon3
-
Sanger Sequencing - Human SLC25A13 knockout HeLa cell lysate (ab258192)Allele-2: 1 bp insertion in exon3
